SIRT1 and cardiac hypertrophy: It has been reported that miR-22 plays roles in heart diseases, such as diabetic cardiomyopathy, cardiac hypertrophy, and ischemia reperfusion injury, by targeting sirt1 (Huang et al., 2013; Du et al., 2016; Tang et al., 2018).